Elevance Health Inc.ELVNYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-20.8%
5Y CAGR-10.0%
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-20.8%/yr
vs +2.0%/yr prior
5Y CAGR
-10.0%/yr
Recent deceleration
Acceleration
-22.8pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.39-19.6%
20240.49-24.3%
20230.64-18.4%
20220.79-3.6%
20210.82+23.4%
20200.66-10.8%
20190.74+2.1%
20180.73+13.3%
20170.64+43.4%
20160.45-